He mea kūpono kēia pahu no ka ʻike kūpono o ka maʻi hepatitis E (HEV) nucleic acid i loko o nā laʻana serum a me nā laʻana stool in vitro.
He kūpono kēia pahu no ka ʻike ʻana i ka maʻi hepatitis A (HAV) nucleic acid i loko o nā laʻana serum a me nā laʻana stool in vitro.
Hoʻohana ʻia kēia pahu no ka ʻike ʻana i ka nui o ka maʻi hepatitis B RNA i loko o ka laʻana serum kanaka.
Hoʻohana ʻia kēia pahu no ka ʻike nui ʻana o ka maʻi hepatitis B maʻi nucleic acid i loko o ka serum kanaka a i ʻole nā laʻana plasma.
Hoʻohana ʻia kēia pahu no ka ʻike genotyping o ka maʻi maʻi hepatitis C (HCV) subtypes 1b, 2a, 3a, 3b a me 6a i loko o nā laʻana serum/plasma o ka maʻi hepatitis C (HCV).Kōkua ia i ka ʻike a me ka mālama ʻana i nā maʻi HCV.
ʻO ka HCV Quantitative Real-Time PCR Kit he in vitro Nucleic Acid Test (NAT) e ʻike a hoʻohālikelike i nā waikawa nucleic Hepatitis C Virus (HCV) i loko o ke koko koko kanaka a i ʻole nā serum samples me ke kōkua o Quantitative Real-Time Polymerase Chain Reaction (qPCR). ) ʻano hana.
Hoʻohana ʻia kēia kime no ka ʻike paʻi ʻana o ke ʻano B, ʻano C a me ke ʻano D i nā laʻana serum/plasma maikaʻi o ka maʻi hepatitis B (HBV)
Hoʻohana ʻia kēia pahu no ka ʻike ʻana i ka nui o ka maʻi hepatitis B i ka waika nucleic i loko o nā laʻana serum kanaka.